Literature DB >> 11980250

Conducting pharmacoepidemiologic research in Denmark.

J Hallas1.   

Abstract

Denmark has one of the worlds most comprehensive registration of its citizens' use of medical and social services. Most databases are population-based and of very high quality. Virtually all employ a mutual person identifier, which renders it technically possible to link any of them with others. There are two prescription registries of interest for research, the OPED and the NJPD, each covering 0.5 million persons. The content of these are described in brief. The most recent Danish data protection act can be viewed as a liberalization of prevailing registry practice. Our most important obstacles for performing record-linkage studies are costs, academic resources and a lack of generally accepted guidelines on the ethics of observational research.

Entities:  

Mesh:

Year:  2001        PMID: 11980250     DOI: 10.1002/pds.638

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  17 in total

1.  Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases.

Authors:  Henrik Svanström; Torbjörn Callréus; Anders Hviid
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Identification of asthmatic children using prescription data and diagnosis.

Authors:  Grete Moth; Peter Vedsted; Po Schiøtz
Journal:  Eur J Clin Pharmacol       Date:  2007-03-27       Impact factor: 2.953

3.  Early discontinuation: more frequent among general practitioners with high levels of prescribing.

Authors:  Dorte Gilså Hansen; Anthony Gichangi; Werner Vach; Lina Hoel Felde; John Larsen
Journal:  Eur J Clin Pharmacol       Date:  2007-07-06       Impact factor: 2.953

4.  Maternal infections during pregnancy and cerebral palsy: a population-based cohort study.

Authors:  Jessica E Miller; Lars Henning Pedersen; Elani Streja; Bodil H Bech; Marshalyn Yeargin-Allsopp; Kim Van Naarden Braun; Diana E Schendel; Deborah Christensen; Peter Uldall; Jørn Olsen
Journal:  Paediatr Perinat Epidemiol       Date:  2013-10-10       Impact factor: 3.980

5.  Cancer patients' first treatment episode with opioids: a pharmaco-epidemiological perspective.

Authors:  Lene Jarlbaek; Jesper Hallas; Jakob Kragstrup; Morten Andersen
Journal:  Support Care Cancer       Date:  2005-09-27       Impact factor: 3.603

6.  Existing data sources for clinical epidemiology: Aarhus University Prescription Database.

Authors:  Vera Ehrenstein; Sussie Antonsen; Lars Pedersen
Journal:  Clin Epidemiol       Date:  2010-12-02       Impact factor: 4.790

7.  Antipsychotics and risk of venous thromboembolism: A population-based case-control study.

Authors:  Anna K Jönsson; Erzsebet Horváth-Puhó; Staffan Hägg; Lars Pedersen; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

8.  Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality.

Authors:  T L Jørgensen; J Hallas; S Friis; J Herrstedt
Journal:  Br J Cancer       Date:  2012-02-21       Impact factor: 7.640

9.  Comparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use--A Descriptive Cross-Sectional Study.

Authors:  Daniel Pilsgaard Henriksen; Lotte Rasmussen; Morten Rix Hansen; Jesper Hallas; Anton Pottegård
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

10.  Maternal use of antibiotics and the risk of childhood febrile seizures: a Danish population-based cohort.

Authors:  Jessica E Miller; Lars Henning Pedersen; Mogens Vestergaard; Jørn Olsen
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.